- Home
- NVCT vs TROO Comparison
NVCT vs TROO Comparison
Compare NVCT & TROO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCT | TROO |
|---|---|---|
| Founded | 2020 | 2005 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.4M | 287.1M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | NVCT | TROO |
|---|---|---|
| Price | $11.11 | $4.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 79.0K | ★ 361.5K |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.55 | $0.53 |
| 52 Week High | $13.34 | $5.28 |
Technical Indicators
Market Signals| Indicator | NVCT | TROO |
|---|---|---|
| Relative Strength Index (RSI) | 61.24 | 61.60 |
| Support Level | $7.79 | $3.44 |
| Resistance Level | N/A | $4.58 |
| Average True Range (ATR) | 0.80 | 0.49 |
| MACD | 0.25 | 0.01 |
| Stochastic Oscillator | 54.78 | 69.82 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.